Sanoculis

Sanoculis
Sanoculis develops MIMS®, a minimally invasive surgical device for glaucoma treatment, creating a drainage channel without implants or stitches.
About
What does Sanoculis do?
Sanoculis is a medical device startup focused on developing innovative solutions for glaucoma treatment. Their flagship product, MIMS® (Minimally Invasive Micro Sclerostomy), is a surgical device designed to create a drainage channel to reduce intraocular pressure (IOP) in glaucoma patients. The MIMS® procedure aims for a long-lasting, safe, and controlled fluid flow without the need for stitches, eye-patches, implants, or stents, thereby reducing post-surgical complications and care costs.
What is Sanoculis's revenue?
StartupHub estimates Sanoculis's annual revenue at $1.8M (range $1.0M to $3.4M, 67% confidence), based on comparable companies in the sector.
Where is Sanoculis headquartered?
Sanoculis is headquartered in Tel Aviv, Israel.
When was Sanoculis founded?
Sanoculis was founded in 2012.
What industry does Sanoculis operate in?
Sanoculis operates in Healthcare, MedTech, Ophthalmology, Medical Device, Glaucoma Treatment, Minimally Invasive Surgery.
How many employees does Sanoculis have?
Sanoculis has approximately 10 people on record.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
Longevity and metabolic health platform offering personalized insights and interventions.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
